Results 171 to 180 of about 34,432 (188)

Real-World Treatment Outcomes in the First and Subsequent Coronavirus Disease 2019 (COVID-19) Hospital Clusters. [PDF]

Cureus
Ohsaki Y, Sasaki T, Umekage Y, Yanada H, Ishikawa M, Yoshida R.   +5 more
europepmc   +1 more source

Antiviral combination treatment of SARS-CoV-2 after repeated treatment failures of remdesivir monotherapy: A case report. [PDF]

IDCases
Bay AC, Clausen MR, Røge BT, Sydenham TV, Steinke K, Pedersen RM, Bang LL, Andersen TE, Jensen A, Madsen LW.   +9 more
europepmc   +1 more source

Propensity Score Methods for Confounding Control in Observational Studies of Therapeutics for COVID-19 Infection. [PDF]

Clin Infect Dis
Hurwitz KE, Rathnayaka N, Hendrickson K, Brookhart MA.   +3 more
europepmc   +1 more source

Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant. [PDF]

Front Public Health
Marbaix S, Simoens S, Clevenbergh P, Van Bleyenbergh P, Liberman K, Dehenau D.   +5 more
europepmc   +1 more source

Repetitive stability study of remdesivir/cyclodextrin complex on the international space station. [PDF]

Sci Rep
Dormán G, Buchholcz B, Puskás I, Szabó P, Varga E, Szente L, Keserű GM, Darvas F.   +7 more
europepmc   +1 more source

Within-host dynamics of antiviral treatment with remdesivir for SARS-CoV-2 infection. [PDF]

J R Soc Interface
Schuh L, Markov PV, Voulgaridi I, Bogogiannidou Z, Mouchtouri VA, Hadjichristodoulou C, Stilianakis NI.   +6 more
europepmc   +1 more source

Comparative Analysis of Neuropsychiatric Adverse Reactions Associated with Remdesivir and Nirmatrelvir/Ritonavir in COVID-19 Treatment: Insights from EudraVigilance Data. [PDF]

J Clin Med
Pacnejer AM, Negru MC, Arseniu AM, Trandafirescu C, Oancea C, Gligor FG, Morgovan C, Butuca A, Dehelean CA.   +8 more
europepmc   +1 more source

Improving clinical care of patients in Nipah outbreaks: moving beyond 'compassionate use'. [PDF]

Lancet Reg Health Southeast Asia
Hassan MZ, Rojek A, Olliaro P, Horby P.
europepmc   +1 more source

Characterizing Public Sentiments and Drug Interactions in the COVID-19 Pandemic Using Social Media: Natural Language Processing and Network Analysis.

J Med Internet Res
Li W, Hua Y, Zhou P, Zhou L, Xu X, Yang J.   +5 more
europepmc   +1 more source